AVE 0.00% 0.3¢ avecho biotechnology limited

progress of the csl / poh collaboration

  1. 72 Posts.
    CSL is due to resport 1/2 year earnings on 17 February 2010.

    I am confident that CSL will post another bumper profit and confirm its previous advice to the market that it remains in acquisition mode.

    It would be timely then for POH management to post some news of the progress of the CSL and POH collaboration agreements for the testing of the suite of CSL pipeline compounds with POH technology.

    Exciting times ahead.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
35 43869108 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 44263580 22
View Market Depth
Last trade - 16.12pm 04/10/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.